The risk or severity of adverse effects can be increased when tetracaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with dantrolene.


The risk or severity of adverse effects can be increased when brotizolam is combined with clomipramine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when sevoflurane is combined with glutethimide.


The risk or severity of adverse effects can be increased when LEVOFLOXACIN is combined with atorvastatin.


The risk or severity of adverse effects can be increased when suprofen is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when pimozide is combined with Pipamperone.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Normethadone.


The risk or severity of adverse effects can be increased when ILOPROST is combined with rasagiline.


The risk or severity of adverse effects can be increased when Bretylium is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when procarbazine is combined with linezolid.


The risk or severity of adverse effects can be increased when lovastatin is combined with DAPTOMYCIN.


The risk or severity of adverse effects can be increased when Tianeptine is combined with formoterol.


The risk or severity of adverse effects can be increased when minoxidil is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when quetiapine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with butamben.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when midazolam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when tolmetin is combined with ibuprofen.


The risk or severity of adverse effects can be increased when captopril is combined with fenbufen.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when codeine is combined with pentazocine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with meclizine.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when butorphanol is combined with triamterene.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when Ramelteon is combined with Retigabine.


The risk or severity of adverse effects can be increased when CALCIUM CARBONATE is combined with misoprostol.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with ciprofloxacin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Gefitinib.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Toloxatone.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when buprenorphine is combined with procarbazine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with diethylstilbestrol.


The risk or severity of adverse effects can be increased when fosinopril is combined with methazolamide.


The risk or severity of adverse effects can be increased when Pentolinium is combined with Vecuronium.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with phenytoin.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when Naftifine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with sulfanilamide.


The risk or severity of adverse effects can be increased when sulpiride is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Bortezomib is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when biperiden is combined with meperidine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when methylergonovine is combined with manidipine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with chloroquine.


The risk or severity of adverse effects can be increased when thalidomide is combined with tolazoline.


The risk or severity of adverse effects can be increased when thalidomide is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when thalidomide is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Tiotropium is combined with meperidine.


The risk or severity of adverse effects can be increased when Nabilone is combined with isradipine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Nabilone is combined with Olmesartan.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Normethadone is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when ILOPROST is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when methysergide is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when methysergide is combined with daunorubicin.


The risk or severity of adverse effects can be increased when meprobamate is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with salicylic acid.


The risk or severity of adverse effects can be increased when buspirone is combined with Remoxipride.


The risk or severity of adverse effects can be increased when salicylic acid is combined with DESONIDE.


The risk or severity of adverse effects can be increased when butorphanol is combined with metolazone.


The risk or severity of adverse effects can be increased when buspirone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when butorphanol is combined with dibucaine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with mitomycin C.


The risk or severity of adverse effects can be increased when lorazepam is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with bumetanide.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with vindesine.


The risk or severity of adverse effects can be increased when chloroquine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when lithium ion is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with HEROIN.


The risk or severity of adverse effects can be increased when butamben is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when sulindac is combined with estrone.


The risk or severity of adverse effects can be increased when methysergide is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with clonazepam.


The risk or severity of adverse effects can be increased when methysergide is combined with Caspofungin.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Enasidenib.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Melatonin.


The risk or severity of adverse effects can be increased when diflunisal is combined with salicylic acid.


The risk or severity of adverse effects can be increased when butalbital is combined with paroxetine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with Fondaparinux.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when nitrendipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with HEROIN.


The risk or severity of adverse effects can be increased when chloramphenicol is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when topiramate is combined with tizanidine.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when methysergide is combined with cisapride.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with epirizole.


The risk or severity of adverse effects can be increased when bupivacaine is combined with proparacaine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with dexamethasone.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with diclofenac.


The risk or severity of adverse effects can be increased when risperidone is combined with Articaine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with tetracaine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with indapamide.


The risk or severity of adverse effects can be increased when Pipamperone is combined with triprolidine.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with alclometasone.


The risk or severity of adverse effects can be increased when Pipamperone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Pipamperone is combined with spironolactone.


The risk or severity of adverse effects can be increased when losartan is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Torasemide.


The risk or severity of adverse effects can be increased when glutethimide is combined with zotepine.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when losartan is combined with furosemide.


The risk or severity of adverse effects can be increased when loxapine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when metoprolol is combined with enalapril.


The risk or severity of adverse effects can be increased when nimodipine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when chloroquine is combined with oxaprozin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Melatonin is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with tegafur.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Phenelzine is combined with dobutamine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when metolazone is combined with diazoxide.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Mersalyl.


The risk or severity of adverse effects can be increased when pimozide is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when bromazepam is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when docetaxel is combined with cinoxacin.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when loratadine is combined with Retigabine.


The risk or severity of adverse effects can be increased when tiapride is combined with maprotiline.


The risk or severity of adverse effects can be increased when Phenelzine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when tacrolimus is combined with actinomycin D.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Butethal.


The risk or severity of adverse effects can be increased when oxymorphone is combined with amobarbital.


The risk or severity of adverse effects can be increased when tetracaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Clofarabine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when tiagabine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with donepezil.


The risk or severity of adverse effects can be increased when SOMATOSTATIN is combined with thiopental.


The risk or severity of adverse effects can be increased when thiothixene is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when haloperidol is combined with atorvastatin.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with loteprednol.


The risk or severity of adverse effects can be increased when isoflurane is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when flurazepam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with rapamycin.


The risk or severity of adverse effects can be increased when isoflurane is combined with glutethimide.


The risk or severity of adverse effects can be increased when flurazepam is combined with thiopental.


The risk or severity of adverse effects can be increased when Pentyl nitrite is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with paroxetine.


The risk or severity of adverse effects can be increased when estazolam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when loteprednol is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with buprenorphine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Difenoxin.


The risk or severity of adverse effects can be increased when nicergoline is combined with Netupitant.


The risk or severity of adverse effects can be increased when loteprednol is combined with malathion.


The risk or severity of adverse effects can be increased when Pirlindole is combined with moclobemide.


The risk or severity of adverse effects can be increased when promethazine is combined with dantrolene.


The risk or severity of adverse effects can be increased when Articaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with trandolapril.


The risk or severity of adverse effects can be increased when amphotericin b is combined with benazepril.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Remoxipride.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with desoximetasone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with nisoldipine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when metoprolol is combined with benazepril.


The risk or severity of adverse effects can be increased when hydromorphone is combined with enflurane.


The risk or severity of adverse effects can be increased when midazolam is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with cilazapril.


The risk or severity of adverse effects can be increased when codeine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when moclobemide is combined with Salbutamol.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with glutethimide.


The risk or severity of adverse effects can be increased when labetalol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when prazepam is combined with triprolidine.


The risk or severity of adverse effects can be increased when paroxetine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with clidinium.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when haloperidol is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Etomidate is combined with fluoxetine.


The risk or severity of adverse effects can be increased when topiramate is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when dapsone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when fosinopril is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when fosinopril is combined with quinapril.


The risk or severity of adverse effects can be increased when fosinopril is combined with bumetanide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with glutethimide.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when zonisamide is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with risperidone.


The risk or severity of adverse effects can be increased when morphine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when morphine is combined with glutethimide.


The risk or severity of adverse effects can be increased when morphine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when ketorolac is combined with Clobetasone.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with imipramine.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when apomorphine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when D-mannitol is combined with papaverine.


The risk or severity of adverse effects can be increased when clidinium is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when procyclidine is combined with buprenorphine.


The risk or severity of adverse effects can be increased when Calcium phosphate is combined with ergocalciferol.


The risk or severity of adverse effects can be increased when benztropine is combined with procyclidine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with formestane.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when methylergonovine is combined with isoniazid.


The risk or severity of adverse effects can be increased when griseofulvin is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when lorazepam is combined with levodopa.


The risk or severity of adverse effects can be increased when pergolide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with tetracaine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with flunarizine.


The risk or severity of adverse effects can be increased when pergolide is combined with mequitazine.


The risk or severity of adverse effects can be increased when olanzapine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when DESONIDE is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when DESONIDE is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Almotriptan is combined with amisulpride.


The risk or severity of adverse effects can be increased when suprofen is combined with equilin.


The risk or severity of adverse effects can be increased when anagrelide is combined with mesalamine.


The risk or severity of adverse effects can be increased when clomipramine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Flupentixol.


The risk or severity of adverse effects can be increased when benztropine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when procaine is combined with primidone.


The risk or severity of adverse effects can be increased when benztropine is combined with pentazocine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when fexofenadine is combined with dantrolene.


The risk or severity of adverse effects can be increased when ramipril is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when ropinirole is combined with nisoldipine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with acebutolol.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when ramipril is combined with carprofen.


The risk or severity of adverse effects can be increased when ketorolac is combined with nabumetone.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when scopolamine is combined with levodopa.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Vecuronium.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when ethanol is combined with procarbazine.


The risk or severity of adverse effects can be increased when trazodone is combined with zolmitriptan.


The risk or severity of adverse effects can be increased when isoflurane is combined with loratadine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when testosterone propionate is combined with methylene blue.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when testosterone propionate is combined with Toloxatone.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with maprotiline.


The risk or severity of adverse effects can be increased when calcium lactate is combined with Doxercalciferol.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with brotizolam.


The risk or severity of adverse effects can be increased when Torasemide is combined with minoxidil.


The risk or severity of adverse effects can be increased when morniflumate is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when procaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when amiodarone is combined with toremifene.


The risk or severity of adverse effects can be increased when nimesulide is combined with Apremilast.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with alclofenac.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with oxymorphone.


The risk or severity of adverse effects can be increased when MELPERONE is combined with amitriptyline.


The risk or severity of adverse effects can be increased when quetiapine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Tolcapone.


The risk or severity of adverse effects can be increased when quetiapine is combined with dyclonine.


The risk or severity of adverse effects can be increased when Icatibant is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when sertraline is combined with procarbazine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Mometasone is combined with physostigmine.


The risk or severity of adverse effects can be increased when thioridazine is combined with thiamylal.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Tiotropium is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with thalidomide.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when propofol is combined with cetirizine.


The risk or severity of adverse effects can be increased when Salsalate is combined with medrysone.


The risk or severity of adverse effects can be increased when epinastine is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when propofol is combined with protriptyline.


The risk or severity of adverse effects can be increased when zonisamide is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when captopril is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Masoprocol is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when methocarbamol is combined with doxepin.


The risk or severity of adverse effects can be increased when betaxolol is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when methazolamide is combined with acetazolamide.


The risk or severity of adverse effects can be increased when diltiazem is combined with hydralazine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when Icatibant is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when equilin is combined with decamethonium.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when dibucaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when amobarbital is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Olaparib is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Dronedarone is combined with oxycodone.


The risk or severity of adverse effects can be increased when Olmesartan is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with ATROPINE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Metipranolol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Perospirone.


The risk or severity of adverse effects can be increased when Fondaparinux is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when ketorolac is combined with resveratrol.


The risk or severity of adverse effects can be increased when methylene blue is combined with methadone.


The risk or severity of adverse effects can be increased when propranolol is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Clevidipine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with resveratrol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when nalbuphine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when furazolidone is combined with apraclonidine.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when apraclonidine is combined with quetiapine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when propofol is combined with methyldopa.


The risk or severity of adverse effects can be increased when propofol is combined with Desloratadine.


The risk or severity of adverse effects can be increased when propofol is combined with Telmisartan.


The risk or severity of adverse effects can be increased when ipratropium is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when propofol is combined with apraclonidine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with baclofen.


The risk or severity of adverse effects can be increased when irbesartan is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when propofol is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Salsalate is combined with loteprednol.


The risk or severity of adverse effects can be increased when thiamylal is combined with zotepine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Deferasirox.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Fosaprepitant.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with irbesartan.


The risk or severity of adverse effects can be increased when Flupentixol is combined with topiramate.


The risk or severity of adverse effects can be increased when pentazocine is combined with topiramate.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with felodipine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with flunisolide.


The risk or severity of adverse effects can be increased when acetazolamide is combined with primidone.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with thiamylal.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Pirlindole.


The risk or severity of adverse effects can be increased when isoflurane is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Milnacipran is combined with reserpine.


The risk or severity of adverse effects can be increased when flunisolide is combined with tubocurarine.


The risk or severity of adverse effects can be increased when benzocaine is combined with paroxetine.


The risk or severity of adverse effects can be increased when apomorphine is combined with doxazosin.


The risk or severity of adverse effects can be increased when codeine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when apomorphine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when sertraline is combined with protriptyline.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with suprofen.


The risk or severity of adverse effects can be increased when flunisolide is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Besifloxacin.


The risk or severity of adverse effects can be increased when flunisolide is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Eprosartan.


The risk or severity of adverse effects can be increased when diflorasone is combined with enoxacin.


The risk or severity of adverse effects can be increased when brotizolam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when brotizolam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with mitoxantrone.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with lomustine.


The risk or severity of adverse effects can be increased when Trospium is combined with tubocurarine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with duloxetine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when acetazolamide is combined with dorzolamide.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when naratriptan is combined with rasagiline.


The risk or severity of adverse effects can be increased when Trospium is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Normethadone is combined with imipramine.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with HEROIN.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with nortriptyline.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with amoxapine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with benazepril.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with acetazolamide.


The risk or severity of adverse effects can be increased when bupivacaine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when diltiazem is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when barnidipine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when zaleplon is combined with lidocaine.


The risk or severity of adverse effects can be increased when meperidine is combined with glutethimide.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Retigabine.


The risk or severity of adverse effects can be increased when Salsalate is combined with acemetacin.


The risk or severity of adverse effects can be increased when zotepine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when temazepam is combined with Butethal.


The risk or severity of adverse effects can be increased when temazepam is combined with amobarbital.


The risk or severity of adverse effects can be increased when temazepam is combined with lithium ion.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with tenoxicam.


The risk or severity of adverse effects can be increased when temazepam is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when ethinyl estradiol is combined with Ospemifene.


The risk or severity of adverse effects can be increased when tropicamide is combined with pirenzepine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Phenelzine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when tropicamide is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when nicergoline is combined with Sorafenib.


The risk or severity of adverse effects can be increased when temazepam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when temazepam is combined with alprazolam.


The risk or severity of adverse effects can be increased when Olopatadine is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with cilazapril.


The risk or severity of adverse effects can be increased when Pizotifen is combined with citalopram.


The risk or severity of adverse effects can be increased when temazepam is combined with loxapine.


The risk or severity of adverse effects can be increased when oxybutynin is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when valsartan is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when nicergoline is combined with progesterone.


The risk or severity of adverse effects can be increased when quinapril is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Pramocaine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with trimipramine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Suvorexant is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Suvorexant is combined with duloxetine.


The risk or severity of adverse effects can be increased when ketamine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when ketamine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Agomelatine.


The risk or severity of adverse effects can be increased when codeine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when amiodarone is combined with Lofexidine.


The risk or severity of adverse effects can be increased when Droxicam is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when chloroxine is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when Droxicam is combined with paramethasone.


The risk or severity of adverse effects can be increased when procaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with thiothixene.


The risk or severity of adverse effects can be increased when epirizole is combined with Mometasone.


The risk or severity of adverse effects can be increased when secobarbital is combined with MELPERONE.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with tenoxicam.


The risk or severity of adverse effects can be increased when pergolide is combined with miconazole.


The risk or severity of adverse effects can be increased when selegiline is combined with tretinoin.


The risk or severity of adverse effects can be increased when Flupentixol is combined with amobarbital.


The risk or severity of adverse effects can be increased when pergolide is combined with nifedipine.


The risk or severity of adverse effects can be increased when fosinopril is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with METAXALONE.


The risk or severity of adverse effects can be increased when pergolide is combined with tacrolimus.


The risk or severity of adverse effects can be increased when epirizole is combined with formestane.


The risk or severity of adverse effects can be increased when pergolide is combined with ranitidine.


The risk or severity of adverse effects can be increased when epirizole is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when sumatriptan is combined with thioridazine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when perphenazine is combined with Retigabine.


The risk or severity of adverse effects can be increased when baclofen is combined with loratadine.


The risk or severity of adverse effects can be increased when butabarbital is combined with olanzapine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with levodopa.


The risk or severity of adverse effects can be increased when Torasemide is combined with streptomycin.


The risk or severity of adverse effects can be increased when butabarbital is combined with methadone.


The risk or severity of adverse effects can be increased when METAXALONE is combined with doxepin.


The risk or severity of adverse effects can be increased when zotepine is combined with clonazepam.


The risk or severity of adverse effects can be increased when zotepine is combined with promethazine.


The risk or severity of adverse effects can be increased when metronidazole is combined with ethanol.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when celecoxib is combined with diflunisal.


The risk or severity of adverse effects can be increased when phenobarbital is combined with glutethimide.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with sertraline.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with nimesulide.


The risk or severity of adverse effects can be increased when duloxetine is combined with sertraline.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when ketorolac is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Rufinamide is combined with nalbuphine.


The risk or severity of adverse effects can be increased when zopiclone is combined with sulpiride.


The risk or severity of adverse effects can be increased when Rufinamide is combined with oxazepam.


The risk or severity of adverse effects can be increased when temazepam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when zopiclone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when flurazepam is combined with etizolam.


The risk or severity of adverse effects can be increased when nicergoline is combined with hydralazine.


The risk or severity of adverse effects can be increased when methysergide is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when doxazosin is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Halazepam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when clorazepate is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with thiamylal.


The risk or severity of adverse effects can be increased when methadone is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with halothane.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with midazolam.


The risk or severity of adverse effects can be increased when clozapine is combined with tretinoin.


The risk or severity of adverse effects can be increased when clozapine is combined with ethotoin.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when clemastine is combined with clidinium.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when etodolac is combined with ketoprofen.


The risk or severity of adverse effects can be increased when epirizole is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Olmesartan is combined with sulindac.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with formestane.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when butabarbital is combined with thiopental.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with efavirenz.


The risk or severity of adverse effects can be increased when butabarbital is combined with ethosuximide.


The risk or severity of adverse effects can be increased when valsartan is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when terbutaline is combined with oxymetazoline.


The risk or severity of adverse effects can be increased when quinacrine is combined with dapsone.


The risk or severity of adverse effects can be increased when epinephrine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when trandolapril is combined with penbutolol.


The risk or severity of adverse effects can be increased when venlafaxine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when quinapril is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when amisulpride is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when enflurane is combined with cocaine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Drospirenone.


The risk or severity of adverse effects can be increased when Apremilast is combined with betamethasone.


The risk or severity of adverse effects can be increased when Articaine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when eperisone is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when amisulpride is combined with zonisamide.


The risk or severity of adverse effects can be increased when scopolamine is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when Remoxipride is combined with dibucaine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Tiotropium is combined with butorphanol.


The risk or severity of adverse effects can be increased when niflumic acid is combined with budesonide.


The risk or severity of adverse effects can be increased when rescinnamine is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when oxprenolol is combined with amitriptyline.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Perospirone.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when diazepam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Remoxipride.


The risk or severity of adverse effects can be increased when loxapine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when oxycodone is combined with amoxapine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when phentolamine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with triamterene.


The risk or severity of adverse effects can be increased when Carbetocin is combined with isradipine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Olmesartan.


The risk or severity of adverse effects can be increased when Olopatadine is combined with budesonide.


The risk or severity of adverse effects can be increased when diclofenac is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when levorphanol is combined with Articaine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with pargyline.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Sitaxsentan.


The risk or severity of adverse effects can be increased when loxapine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with methazolamide.


The risk or severity of adverse effects can be increased when celecoxib is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when alprazolam is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when captopril is combined with Naftifine.


The risk or severity of adverse effects can be increased when zopiclone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when alprazolam is combined with bromazepam.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Apremilast.


The risk or severity of adverse effects can be increased when nicergoline is combined with prednisone.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with dexamethasone.


The risk or severity of adverse effects can be increased when nicergoline is combined with astemizole.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Droxicam.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when triamcinolone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when pirenzepine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when triamcinolone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Phenelzine is combined with triamterene.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Asenapine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with clidinium.


The risk or severity of adverse effects can be increased when docetaxel is combined with Vismodegib.


The risk or severity of adverse effects can be increased when diflunisal is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Tramadol is combined with sumatriptan.


The risk or severity of adverse effects can be increased when methoxamine is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when Tramadol is combined with METAXALONE.


The risk or severity of adverse effects can be increased when manidipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when epoprostenol is combined with thalidomide.


The risk or severity of adverse effects can be increased when Lofexidine is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when Lofexidine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Lofexidine is combined with methazolamide.


The risk or severity of adverse effects can be increased when enflurane is combined with promethazine.


The risk or severity of adverse effects can be increased when Trospium is combined with quinidine.


The risk or severity of adverse effects can be increased when tubocurarine is combined with butorphanol.


The risk or severity of adverse effects can be increased when Lofexidine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with selegiline.


The risk or severity of adverse effects can be increased when Linagliptin is combined with quinapril.


The risk or severity of adverse effects can be increased when Pirlindole is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when naratriptan is combined with tiapride.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with topiramate.


The risk or severity of adverse effects can be increased when mecamylamine is combined with hydralazine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with acetazolamide.


The risk or severity of adverse effects can be increased when nitric oxide is combined with lidocaine.


The risk or severity of adverse effects can be increased when meprobamate is combined with amisulpride.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with felbamate.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with norfloxacin.


The risk or severity of adverse effects can be increased when prazepam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when prazepam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with mecamylamine.


The risk or severity of adverse effects can be increased when amisulpride is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with acemetacin.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with amisulpride.


The risk or severity of adverse effects can be increased when acemetacin is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when dyphylline is combined with formoterol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Clevidipine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with pirenzepine.


The risk or severity of adverse effects can be increased when buspirone is combined with nitrazepam.


The risk or severity of adverse effects can be increased when etizolam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with suprofen.


The risk or severity of adverse effects can be increased when barnidipine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with alclofenac.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with clidinium.


The risk or severity of adverse effects can be increased when antipyrine is combined with paramethasone.


The risk or severity of adverse effects can be increased when ceritinib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with droperidol.


The risk or severity of adverse effects can be increased when antipyrine is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Toloxatone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Pirlindole.


The risk or severity of adverse effects can be increased when Tramadol is combined with Eletriptan.


The risk or severity of adverse effects can be increased when butamben is combined with tizanidine.


The risk or severity of adverse effects can be increased when morphine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when pentobarbital is combined with phenobarbital.


The risk or severity of adverse effects can be increased when Fidaxomicin is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when methysergide is combined with Darunavir.


The risk or severity of adverse effects can be increased when fenoprofen is combined with ibuprofen.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with methadone.


The risk or severity of adverse effects can be increased when Fidaxomicin is combined with fluvastatin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with thiamylal.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with bupropion.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with METAXALONE.


The risk or severity of adverse effects can be increased when gabapentin is combined with ketamine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with venlafaxine.


The risk or severity of adverse effects can be increased when zolpidem is combined with Milnacipran.


The risk or severity of adverse effects can be increased when nisoldipine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when nicergoline is combined with tetracycline.


The risk or severity of adverse effects can be increased when meperidine is combined with triprolidine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when meperidine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when meperidine is combined with spironolactone.


The risk or severity of adverse effects can be increased when amphotericin b is combined with methazolamide.


The risk or severity of adverse effects can be increased when hexetidine is combined with eperisone.


The risk or severity of adverse effects can be increased when secobarbital is combined with nefazodone.


The risk or severity of adverse effects can be increased when Phenelzine is combined with sertraline.


The risk or severity of adverse effects can be increased when halothane is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with gabapentin.


The risk or severity of adverse effects can be increased when Droxicam is combined with acemetacin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when celecoxib is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with glutethimide.


The risk or severity of adverse effects can be increased when benztropine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when dapsone is combined with phenazopyridine.


The risk or severity of adverse effects can be increased when levorphanol is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when oxycodone is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Etomidate is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Nepafenac.


The risk or severity of adverse effects can be increased when rasagiline is combined with thioridazine.


The risk or severity of adverse effects can be increased when Torasemide is combined with benazepril.


The risk or severity of adverse effects can be increased when pimozide is combined with baclofen.


The risk or severity of adverse effects can be increased when morphine is combined with enalapril.


The risk or severity of adverse effects can be increased when Pizotifen is combined with duloxetine.


The risk or severity of adverse effects can be increased when rasagiline is combined with pimozide.


The risk or severity of adverse effects can be increased when tolmetin is combined with sulindac.


The risk or severity of adverse effects can be increased when rasagiline is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when clomiphene is combined with atorvastatin.


The risk or severity of adverse effects can be increased when tolmetin is combined with chloroquine.


The risk or severity of adverse effects can be increased when pimozide is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Alogliptin is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when morphine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with flunarizine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when thiothixene is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Pizotifen is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with nimesulide.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with DESONIDE.


The risk or severity of adverse effects can be increased when promazine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when gabapentin is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when gabapentin is combined with pravastatin.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with niflumic acid.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with isoproterenol.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with DALFOPRISTIN.


The risk or severity of adverse effects can be increased when amphotericin b is combined with atenolol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with zopiclone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with butalbital.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Milnacipran.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with captopril.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with acebutolol.


The risk or severity of adverse effects can be increased when Telmisartan is combined with mesalamine.


The risk or severity of adverse effects can be increased when oxazepam is combined with fludiazepam.


The risk or severity of adverse effects can be increased when zonisamide is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when triprolidine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when felbamate is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when linezolid is combined with risperidone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when lisinopril is combined with hydralazine.


The risk or severity of adverse effects can be increased when budesonide is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with resveratrol.


The risk or severity of adverse effects can be increased when Linagliptin is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when tenoxicam is combined with equilin.


The risk or severity of adverse effects can be increased when tolazoline is combined with terazosin.


The risk or severity of adverse effects can be increased when thiopental is combined with atorvastatin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with equilin.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with zonisamide.


The risk or severity of adverse effects can be increased when EDTA is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with tiagabine.


The risk or severity of adverse effects can be increased when quazepam is combined with doxepin.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with isradipine.


The risk or severity of adverse effects can be increased when oxazepam is combined with lidocaine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when ketamine is combined with amoxapine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when methadone is combined with sulpiride.


The risk or severity of adverse effects can be increased when zonisamide is combined with sertraline.


The risk or severity of adverse effects can be increased when mepivacaine is combined with prazepam.


The risk or severity of adverse effects can be increased when Milnacipran is combined with amisulpride.


The risk or severity of adverse effects can be increased when niflumic acid is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when enflurane is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when enalapril is combined with celecoxib.


The risk or severity of adverse effects can be increased when ibuprofen is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with brotizolam.


The risk or severity of adverse effects can be increased when cetirizine is combined with tizanidine.


The risk or severity of adverse effects can be increased when mirtazapine is combined with celiprolol.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with risperidone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with meclizine.


The risk or severity of adverse effects can be increased when SIMEPREVIR is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when Fospropofol is combined with tetracaine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Vilazodone is combined with loxapine.


The risk or severity of adverse effects can be increased when Tramadol is combined with methazolamide.


The risk or severity of adverse effects can be increased when Flupentixol is combined with triazolam.


The risk or severity of adverse effects can be increased when Asenapine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when imipramine is combined with nadolol.


The risk or severity of adverse effects can be increased when imipramine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when methadone is combined with dyclonine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with fluocinonide.


The risk or severity of adverse effects can be increased when Clofarabine is combined with labetalol.


The risk or severity of adverse effects can be increased when linezolid is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Clofarabine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with doxazosin.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when ethotoin is combined with Retigabine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with olanzapine.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when cilazapril is combined with Apremilast.


The risk or severity of adverse effects can be increased when lithium ion is combined with METAXALONE.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with metoclopramide.


The risk or severity of adverse effects can be increased when zopiclone is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Olmesartan is combined with ibuprofen.


The risk or severity of adverse effects can be increased when paroxetine is combined with thiothixene.


The risk or severity of adverse effects can be increased when paroxetine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with amoxapine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with resveratrol.


The risk or severity of adverse effects can be increased when Tiotropium is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when oxprenolol is combined with desipramine.


The risk or severity of adverse effects can be increased when sulpiride is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Nabilone is combined with atenolol.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with butamben.


The risk or severity of adverse effects can be increased when docetaxel is combined with ifosfamide.


The risk or severity of adverse effects can be increased when nimesulide is combined with betamethasone.


The risk or severity of adverse effects can be increased when Etidocaine is combined with felbamate.


The risk or severity of adverse effects can be increased when Olopatadine is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when nefazodone is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with prednisone.


The risk or severity of adverse effects can be increased when Masoprocol is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when orphenadrine is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when mepivacaine is combined with doxepin.


The risk or severity of adverse effects can be increased when Masoprocol is combined with amcinonide.


The risk or severity of adverse effects can be increased when orphenadrine is combined with pancuronium.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with sotalol.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with norfloxacin.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with ethotoin.


The risk or severity of adverse effects can be increased when reserpine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when HEROIN is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when sulindac is combined with alclofenac.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when leflunomide is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Paliperidone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when promethazine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when docetaxel is combined with dexamethasone.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when mefloquine is combined with dapsone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when lorazepam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Pirlindole is combined with formoterol.


The risk or severity of adverse effects can be increased when THYMOL is combined with diltiazem.


The risk or severity of adverse effects can be increased when nefazodone is combined with droperidol.


The risk or severity of adverse effects can be increased when Asenapine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when nortriptyline is combined with clomipramine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when floctafenine is combined with nimesulide.


The risk or severity of adverse effects can be increased when Asenapine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when phenylephrine is combined with phenmetrazine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with captopril.


The risk or severity of adverse effects can be increased when clonidine is combined with scopolamine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with acebutolol.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Trospium.


The risk or severity of adverse effects can be increased when methysergide is combined with nelfinavir.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with venlafaxine.


The risk or severity of adverse effects can be increased when methysergide is combined with lovastatin.


The risk or severity of adverse effects can be increased when methysergide is combined with indinavir.


The risk or severity of adverse effects can be increased when primidone is combined with secobarbital.


The risk or severity of adverse effects can be increased when Halazepam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Naftifine is combined with fenbufen.


The risk or severity of adverse effects can be increased when Remoxipride is combined with dyclonine.


The risk or severity of adverse effects can be increased when pargyline is combined with metaproterenol.


The risk or severity of adverse effects can be increased when ketorolac is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Naftifine is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when promazine is combined with HEROIN.


The risk or severity of adverse effects can be increased when mepivacaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when floctafenine is combined with fenbufen.


The risk or severity of adverse effects can be increased when METAXALONE is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when floctafenine is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when thiamylal is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when promazine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with moclobemide.


The risk or severity of adverse effects can be increased when tizanidine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when ethotoin is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Pipamperone is combined with triamterene.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with methadone.


The risk or severity of adverse effects can be increased when fosinopril is combined with trandolapril.


The risk or severity of adverse effects can be increased when methylergonovine is combined with olanzapine.


The risk or severity of adverse effects can be increased when salicylamide is combined with alclofenac.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with loteprednol.


The risk or severity of adverse effects can be increased when Lurasidone is combined with doxepin.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with suprofen.


The risk or severity of adverse effects can be increased when Pipamperone is combined with methylphenidate.


The risk or severity of adverse effects can be increased when propranolol is combined with methazolamide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with cocaine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with zopiclone.


The risk or severity of adverse effects can be increased when propantheline is combined with methscopolamine.


The risk or severity of adverse effects can be increased when thalidomide is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when bromocriptine is combined with quinidine.


The risk or severity of adverse effects can be increased when pramipexole is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with promethazine.


The risk or severity of adverse effects can be increased when quinidine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Pipamperone is combined with mecamylamine.


The risk or severity of adverse effects can be increased when salicylamide is combined with Droxicam.


The risk or severity of adverse effects can be increased when diflorasone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when resveratrol is combined with Propacetamol.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with butamben.


The risk or severity of adverse effects can be increased when Remoxipride is combined with promethazine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with triprolidine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with epirizole.


The risk or severity of adverse effects can be increased when isoflurane is combined with nicardipine.


The risk or severity of adverse effects can be increased when sulindac is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when sulindac is combined with Halobetasol.


The risk or severity of adverse effects can be increased when isoflurane is combined with efavirenz.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Melatonin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Normethadone.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when aspirin is combined with celecoxib.


The risk or severity of adverse effects can be increased when Bortezomib is combined with fosinopril.


The risk or severity of adverse effects can be increased when thalidomide is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when proparacaine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with desipramine.


The risk or severity of adverse effects can be increased when chloroquine is combined with epirizole.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when oxymorphone is combined with doxepin.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when apomorphine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with dantrolene.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Conivaptan is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with budesonide.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with efavirenz.


The risk or severity of adverse effects can be increased when flurazepam is combined with felbamate.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with levodopa.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Melatonin.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when methylergonovine is combined with oxybutynin.


The risk or severity of adverse effects can be increased when lidocaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when prilocaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when procaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when METHAMPHETAMINE is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when propofol is combined with lisinopril.


The risk or severity of adverse effects can be increased when Melatonin is combined with clidinium.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with pilocarpine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Spirapril is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when imipramine is combined with buspirone.


The risk or severity of adverse effects can be increased when rasagiline is combined with olanzapine.


The risk or severity of adverse effects can be increased when morphine is combined with clidinium.


The risk or severity of adverse effects can be increased when phenobarbital is combined with levodopa.


The risk or severity of adverse effects can be increased when rasagiline is combined with methadone.


The risk or severity of adverse effects can be increased when zaleplon is combined with fexofenadine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when clomipramine is combined with nadolol.


The risk or severity of adverse effects can be increased when propantheline is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when loxapine is combined with flurazepam.


The risk or severity of adverse effects can be increased when phenobarbital is combined with butamben.


The risk or severity of adverse effects can be increased when loxapine is combined with tizanidine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Normethadone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when triazolam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when vigabatrin is combined with sertraline.


The risk or severity of adverse effects can be increased when isoflurane is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when alprazolam is combined with dantrolene.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when levodopa is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with tizanidine.


The risk or severity of adverse effects can be increased when ramipril is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Melatonin.


The risk or severity of adverse effects can be increased when papaverine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when amisulpride is combined with trimipramine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when duloxetine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when ILOPROST is combined with imipramine.


The risk or severity of adverse effects can be increased when propantheline is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when LISURIDE is combined with danazol.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with promethazine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with clonazepam.


The risk or severity of adverse effects can be increased when Lacidipine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when dyclonine is combined with trimipramine.


The risk or severity of adverse effects can be increased when dyclonine is combined with procaine.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when methscopolamine is combined with Methylscopolamine bromide.